Prenetics Global Limited

NASDAQ:PRE

Medical - Diagnostics & Research

Healthcare
$10.35 +2.19%

+$0.43 today

Market cap
$185.61M
Beta
0.24
P/E (TTM)
-4.9
EPS (TTM)
-$4.18
52W Low $7.18High $23.63

Volume 1.58M

Average 0.22M

PRE Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Prenetics Global LimitedNASDAQ: PRE

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 64.8%

Gross margin was 64.8% in Q1 FY2026, up 22.3 pp from a year earlier. On a trailing-twelve-month basis it was 58.3%, up 12.7 pp year over year. Over 3 fiscal years it widened by 25.3 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
64.8%+5.3 pp QoQ
Last fiscal yearDec 2025
52.8%+2.5 pp YoY
LTMMar 2026
58.3%+12.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+22.3 pp——
1 year+2.5 pp——
3 years+25.3 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
52.8%
Year-over-year change
+2.5pp

Gross Margin vs competitors

How PRE compares with its peers on the latest reported figures

  • PRE's LTM Mar 2026 gross margin of 58.3% is the 7th highest of the 11 companies compared; the peer median is 71.6%.
  • Its year-over-year change of +12.7 pp is the highest of 11, against a peer median of -0.2 pp.
  • Over three fiscal years its change of +25.3 pp compares with a peer median of +3.2 pp.
PRE Competitors Peer median
Gross Margin for PRE and competitors
Company Period LTM level YoY 3-year change
SGMOSangamo Therapeutics, Inc.LTM Mar 2026100.0% +0.0 pp-8.3 pp
TLSITriSalus Life Sciences, Inc.LTM Mar 202685.1% -0.5 pp+2.8 pp
CDXSCodexis, Inc.LTM Mar 202683.9% +12.4 pp+14.2 pp
MXCTMaxCyte, Inc.LTM Mar 202680.7% -0.2 pp-7.3 pp
ARMPArmata Pharmaceuticals, Inc.LTM Mar 202672.2% +1.7 pp+604.5 pp
PROFProfound Medical Corp.LTM Mar 202671.1% +4.4 pp+25.6 pp
PREPrenetics Global LimitedLTM Mar 202658.3% +12.7 pp+25.3 pp
STIMNeuronetics, Inc.LTM Mar 202648.0% -15.6 pp-27.8 pp
OSUROraSure Technologies, Inc.LTM Mar 202641.0% -1.5 pp+3.6 pp
IMDXInsight Molecular Diagnostics Inc.LTM Mar 202619.5% -33.1 pp+6.6 pp
ATLNAtlantic International Corp.LTM Dec 202510.6% -0.1 pp-1.7 pp
Peer median (excluding PRE) 71.6%-0.2 pp+3.2 pp

Competitors are the stored peer set for PRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.53M13.16M21.74M30.62M92.39M
Cost of Revenue8.93M9.55M12.91M15.22M43.6M
Gross Profit3.6M3.62M8.83M15.4M48.79M
Gross Margin28.7%27.5%40.6%50.3%52.8%
Research & Development6.39M5.99M11.66M10.92M5.13M
Selling, General & Admin53.67M64.08M49.68M55.37M79.8M
Operating Expenses60.26M69.64M60.74M63.54M86.92M
Depreciation & Amortization7.35M7.54M7.79M5.93M3.78M
EBITDA(209.16M)(218.04M)(47.9M)(51.57M)(32.19M)
EBITDA Margin-1668.9%-1656.3%-220.3%-168.4%-34.8%
Operating Income(56.66M)(66.02M)(51.91M)(48.14M)(38.13M)
Operating Margin-452.1%-501.5%-238.7%-157.2%-41.3%
Interest Income201472K3.92M2.04M1.04M
Interest Expense42.23K242K119.66K203K241K
Other Income / Expenses(159.89M)(159.8M)(4.76M)(9.56M)1.92M
Income Before Tax(216.55M)(225.82M)(56.67M)(57.7M)(36.21M)
Pre-Tax Margin-1727.9%-1715.4%-260.6%-188.4%-39.2%
Income Tax Expense2.57M(245K)(269.36K)(7.87M)34K
Net Income(174.01M)(190.45M)(62.72M)(46.3M)(37.71M)
Net Margin-1388.4%-1446.8%-288.5%-151.2%-40.8%
EPS (Basic)(47.04)(37.57)(5.58)(3.64)(2.68)
EPS (Diluted)(47.04)(37.57)(5.58)(3.64)(2.68)
Weighted Avg Shares3.7M5.07M11.25M12.71M14.05M
Weighted Avg Shares (Diluted)3.7M5.07M11.25M12.71M14.05M

Prenetics Global Limited

NASDAQ:PRE

Intrinsic Alpha fair value

Locked

Current Price

$10.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.